nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2013-17-6-56-70nefr-421Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESПОСТОЯННЫЙ СОСУДИСТЫЙ ДОСТУП ДЛЯ ГЕМОДИАЛИЗА: СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯPERMANENT VASCULAR ACCESS FOR HEMODIALYSIS: A MODERN VIEWАлфёровС. В.AlferovS. V.

Кафедра факультетской хирургии

197022, ул. Л.Толстого, д. 6/8. Тел. 8(905)-203-09- 88

svaram@mail.ruКарповС. А.KarpovS. A.

Кафедра факультетской хирургии

ГринёвК. М.GrinevK. M.ВасильевА. Н.VasilyevA. N.

кафедра пропедевтики внутренних болезней

Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. ПавловаРоссияЛенинградская областная клиническая больницаРоссия2013100620131765670Copyright © Алфёров С.В., Карпов С.А., Гринёв К.М., Васильев А.Н., 20132013Алфёров С.В., Карпов С.А., Гринёв К.М., Васильев А.Н.Alferov S.V., Karpov S.A., Grinev K.M., Vasilyev A.N.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/421

Благодаря использованию заместительной почечной терапии на современном этапе развития медицины возможна полная медицинская и социальная реабилитация пациентов с терминальной стадией поражения почек. При этом программному гемодиализу отводится особое место, как основному методу экстракорпоральной детоксикации. Важным условием успешности лечения больных на гемодиализе является выбор оптимального постоянного сосудистого доступа и поддержание адекватно функционирующего доступа к крови на протяжении всей жизни больного. Несмотря на множество видов и модификаций, до сих пор нативная артериовенозная фистула является наиболее предпочтительным доступом к крови. Артериовенозные графты являются доступами второй линии. Хотя в некоторых случаях порядок выбора сосудистого доступа может изменяться. Правильное использование, уход и своевременная хирургическая коррекция позволяют сохранять постоянный сосудистый доступ длительное время, снижая число осложнений последнего. Это, в свою очередь, способствует повышению выживаемости данной категории больных.

Авторы заявляют об отсутствии конфликта интересов.

At the modern period of medicine using the renal replacement therapy let reach full medical and social rehabilitation of patients with end-stage renal disease. The hemodialysis is the main method of extracorporal detoxication. The successful hemodialysis therapy depends on choosing the vascular access and maintaining it good condition while all patients life. In spite of various modification of blood accesses the native arteriovenous fistula is the most preferable type of vascular access for hemodialysis. The arteriovenous grafts are at the second line. Some different cases demand individual approach to choice the vascular access. Careful using, timely monitoring and revision keep saving the access for a long time and reducing a risk of complication. It can improve the quality of life patients with ESRD.

гемодиализартериовенозный доступартериовенозная фистулаграфтперманентный туннельный катетерhemodialysisarterio-venous accessarterio-venous fistulagraftpermanent tunneled catheterReferencesЕрмоленко ВМ. Хронический гемодиализ. Медицина, М., 1982; 278сЕрмоленко ВМ. Хронический гемодиализ. Медицина, М., 1982; 278сKolff WJ, Berk HTh. The artificial kidney: a dialyzer with a great area. ActaMedScand1944; 117:121-134Kolff WJ, Berk HTh. The artificial kidney: a dialyzer with a great area. ActaMedScand1944; 117:121-134Quinton WE, Dillard D, Scribner BH. Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 1960; 104-113Quinton WE, Dillard D, Scribner BH. Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 1960; 104-113Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966; 275 (20): 1089–1092Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966; 275 (20): 1089–1092Dunlop MG, Mackinlay JY, Jenkins AM. Vascular access: experience with the brachiocephalic fistula. Ann R Coll Surg Engl 1986; 68:203-206Dunlop MG, Mackinlay JY, Jenkins AM. Vascular access: experience with the brachiocephalic fistula. Ann R Coll Surg Engl 1986; 68:203-206Stonebridge PA, Edington D, Jenkins AM. ‘Brachial/basilic vein’ transposition forvascular access. J R Coll Surg Edinb 1995; 40:219-220Stonebridge PA, Edington D, Jenkins AM. ‘Brachial/basilic vein’ transposition forvascular access. J R Coll Surg Edinb 1995; 40:219-220Bryan FA. Seventh Annual Progress ReportOct. 1, 1974 – Oct. 1, 1975 Report № AK-7-7-1387. Research Triangle Institute, Triangle Park, NC. The National Dialysis Registry – Artificial Kidneys – Chronic Uremia Program, National Institutes of Health, Bethesda, MD, 1975Bryan FA. Seventh Annual Progress ReportOct. 1, 1974 – Oct. 1, 1975 Report № AK-7-7-1387. Research Triangle Institute, Triangle Park, NC. The National Dialysis Registry – Artificial Kidneys – Chronic Uremia Program, National Institutes of Health, Bethesda, MD, 1975Geis WP, Giacchino J. A game plan for vascular access for hemodialysis. Surgical Rounds 1980; 132(3):332-335Geis WP, Giacchino J. A game plan for vascular access for hemodialysis. Surgical Rounds 1980; 132(3):332-335Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicaemia in dialysis patients:incidence, risk factors and prognosis. Kidney Int 1999; 55: 1081-1090Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicaemia in dialysis patients:incidence, risk factors and prognosis. Kidney Int 1999; 55: 1081-1090Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can’t live without them. Kidney Int 1999; 56: 1-17Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can’t live without them. Kidney Int 1999; 56: 1-17U.S. Renal Data System. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. Am J Kidney Dis 1997; 30(Suppl.1):S160- S177U.S. Renal Data System. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. Am J Kidney Dis 1997; 30(Suppl.1):S160- S177Feldman HI, Kobrin S, Wasserstein A. Hemodialysis Vascular Access Morbidity. J Am Soc Nephrol 1996; 7:523-535Feldman HI, Kobrin S, Wasserstein A. Hemodialysis Vascular Access Morbidity. J Am Soc Nephrol 1996; 7:523-535Chazan JA, London MR, Pono L. The impact of diagnosisrelated groups on the cost ofhospitalisation for end-stage renal disease patients at Rhode Island Hospital from 1987 to1990. Am J Kidney Dis 1992; 6:523-525Chazan JA, London MR, Pono L. The impact of diagnosisrelated groups on the cost ofhospitalisation for end-stage renal disease patients at Rhode Island Hospital from 1987 to1990. Am J Kidney Dis 1992; 6:523-525Смирнов АВ. Заместительная почечная терапия. Нефрология 2011; 15(1): 33-46Смирнов АВ. Заместительная почечная терапия. Нефрология 2011; 15(1): 33-46Енькина ТН, Лукичев БГ, Енькин АА, Гринев КМ. Влияние шунтового кровотока по артериовенозной фистуле на развитие сердечной недостаточности у больных с хронической почечной недостаточностью, корригированной программным гемодиализом. Нефрология 2000; 4(1):48-52Енькина ТН, Лукичев БГ, Енькин АА, Гринев КМ. Влияние шунтового кровотока по артериовенозной фистуле на развитие сердечной недостаточности у больных с хронической почечной недостаточностью, корригированной программным гемодиализом. Нефрология 2000; 4(1):48-52Rutherford RB. Rutherford’s vascular surgery / Cronenwett Jack L., Johnston K. Wayne; associate editors, Cambria Richard et al.7th ed. Philadelphia: Saunders Elsevier, 2010: 1169-1173Rutherford RB. Rutherford’s vascular surgery / Cronenwett Jack L., Johnston K. Wayne; associate editors, Cambria Richard et al.7th ed. Philadelphia: Saunders Elsevier, 2010: 1169-1173Wilson SE. Vascular Access. Principles and Practice / Samuel Eric Wilson. – 5th edition. Philadelphia: Lippincott Williams & Wilkins, a Wolter Kluwer business, 2010:173-174Wilson SE. Vascular Access. Principles and Practice / Samuel Eric Wilson. – 5th edition. Philadelphia: Lippincott Williams & Wilkins, a Wolter Kluwer business, 2010:173-174NKF-DOQI clinical practice guidelines for vascular access. New York, National Kidney Foundation, 1997; 191pNKF-DOQI clinical practice guidelines for vascular access. New York, National Kidney Foundation, 1997; 191pKonner K. Primary vascular access in diabetic patients: an audit. Nephrol Dial Transplant 2000 Sep; 15(9): 1317-1325Konner K. Primary vascular access in diabetic patients: an audit. Nephrol Dial Transplant 2000 Sep; 15(9): 1317-1325Konner K, Nonnast-Daniel B, Ritz E. The Arteriovenous Fistula. Journal of the American Society of Nefrology 2003; 14: 1669-1680Konner K, Nonnast-Daniel B, Ritz E. The Arteriovenous Fistula. Journal of the American Society of Nefrology 2003; 14: 1669-1680Wixon CL, Hughes JD, Mills JL. Understending strategies for the treatment of ischemic steal syndrome after hemodialysis access. J Am Coll Surg 2000 Sept; 191(3): 301-310Wixon CL, Hughes JD, Mills JL. Understending strategies for the treatment of ischemic steal syndrome after hemodialysis access. J Am Coll Surg 2000 Sept; 191(3): 301-310Dhingra RK, Young EW, Hulbert-Shearon TE et al. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001 Oct; 60(4): 1443-1451Dhingra RK, Young EW, Hulbert-Shearon TE et al. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001 Oct; 60(4): 1443-1451Kojecky Z, Utikal P, Sekanina Z et al., Venous hypertension following average arterio-venous fistula for haemodialysis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002 Dec; 146(2):77-79Kojecky Z, Utikal P, Sekanina Z et al., Venous hypertension following average arterio-venous fistula for haemodialysis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002 Dec; 146(2):77-79Marr KA, Sexton DJ, Conlon PJ et al. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997 Aug 15; 127(4): 275-280Marr KA, Sexton DJ, Conlon PJ et al. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997 Aug 15; 127(4): 275-280Verghese S, Padmaja P, Sudha P et al. Central venous catheter related infections. J Commun Dis 1999 Mar; 31(1): 1-4Verghese S, Padmaja P, Sudha P et al. Central venous catheter related infections. J Commun Dis 1999 Mar; 31(1): 1-4Rodriguez JA, Armadans L, Ferrer E et al. The function of permanent vascular access. Nephrol Dial Transplant 2000; 15(3):402-408Rodriguez JA, Armadans L, Ferrer E et al. The function of permanent vascular access. Nephrol Dial Transplant 2000; 15(3):402-408Chin AI, Chang W, Fitzgerald JT et al. Intra-access blood flow in patients with newly created upper-arm arteriovenous native fistulae for hemodialysis access. Am J Kidney Dis 2004;44(5):850- 858Chin AI, Chang W, Fitzgerald JT et al. Intra-access blood flow in patients with newly created upper-arm arteriovenous native fistulae for hemodialysis access. Am J Kidney Dis 2004;44(5):850- 858Hemodialysis Clinical Practice Guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006; 17(Suppl 1):S1-27Hemodialysis Clinical Practice Guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006; 17(Suppl 1):S1-27K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations 2006 Updates Hemodialysis adequacy Peritoneal Dialysis Adequacy Vascular Access. Am J Kidney Dis 2006; 48(Suppl 1):S1-158K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations 2006 Updates Hemodialysis adequacy Peritoneal Dialysis Adequacy Vascular Access. Am J Kidney Dis 2006; 48(Suppl 1):S1-158Gradman WS, Laub J, Cohen W. Femoral vein transposition for arteriovenous hemodialysis access: improved patient selection and intraoperative measures reduce postoperative ischemia. J Vasc Surg 2005; 41(2):279-284Gradman WS, Laub J, Cohen W. Femoral vein transposition for arteriovenous hemodialysis access: improved patient selection and intraoperative measures reduce postoperative ischemia. J Vasc Surg 2005; 41(2):279-284Hurt AV, Batello-Cruz M, Skipper BJ et al. Bovine carotid artery heterografts versus polytetrafluoroethylene grafts. A prospective, randomized study. Am J Surg 1983; 146(6):844-847Hurt AV, Batello-Cruz M, Skipper BJ et al. Bovine carotid artery heterografts versus polytetrafluoroethylene grafts. A prospective, randomized study. Am J Surg 1983; 146(6):844-847Liu Z, Zhu B, Wang X et al. Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts. Kidney Int 2007; 72(10):1249-1254Liu Z, Zhu B, Wang X et al. Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts. Kidney Int 2007; 72(10):1249-1254Canaud B. Formaldehyde-fixed arterial allograft as a novel vascular access alternative in end-stage renal disease patients. Kidney Int 2007; 72(10):1179-1181Canaud B. Formaldehyde-fixed arterial allograft as a novel vascular access alternative in end-stage renal disease patients. Kidney Int 2007; 72(10):1179-1181Hurlbert SN, Mattos MA, Henretta JP et al. Long-term patency rates, complications and cost-effectiveness of polytetrafluoroethylene (PTFE) grafts for hemodialysis access: a prospective study that compares Impra versus Gore-tex grafts. Cardiovasc Surg 1998; 6:652-656Hurlbert SN, Mattos MA, Henretta JP et al. Long-term patency rates, complications and cost-effectiveness of polytetrafluoroethylene (PTFE) grafts for hemodialysis access: a prospective study that compares Impra versus Gore-tex grafts. Cardiovasc Surg 1998; 6:652-656Lenz BJ, Veldenz HC, Dennis JW et al. A three-year followup on standard versus thin wall ePTFE grafts for hemodialysis. J Vasc Surg 1998; 28(3):464-470Lenz BJ, Veldenz HC, Dennis JW et al. A three-year followup on standard versus thin wall ePTFE grafts for hemodialysis. J Vasc Surg 1998; 28(3):464-470Schuman ES, Standage BA, Ragsdale JW, Gross GF. Reinforced versus non reinforced polytetrafluoroethylene grafts for hemodialysis access. Am J Surg 1997; 173:407Schuman ES, Standage BA, Ragsdale JW, Gross GF. Reinforced versus non reinforced polytetrafluoroethylene grafts for hemodialysis access. Am J Surg 1997; 173:407Miller CD, Robbin ML, Barker J, Allon M. Comparison of arteriovenous grafts in the thigh and upper extremities in hemodialysis patients. J Am Soc Nephrol 2003; 14(11):2942-2947Miller CD, Robbin ML, Barker J, Allon M. Comparison of arteriovenous grafts in the thigh and upper extremities in hemodialysis patients. J Am Soc Nephrol 2003; 14(11):2942-2947Ram SJ, Sachdeva BA, Caldito GC et al. Thigh grafts contribute significantly to patients’ time on dialysis. Clin J Am Soc Nephrol 2010; 5(7):1229-1234Ram SJ, Sachdeva BA, Caldito GC et al. Thigh grafts contribute significantly to patients’ time on dialysis. Clin J Am Soc Nephrol 2010; 5(7):1229-1234Hessinger M, Zitta S, Holzer H, Tiesenhausen K. [Dialock® – an alternative to Permcath trade mark and Access Graft] [Article in German]. Zentralbl Chir 2003; 128 (9): 753–756Hessinger M, Zitta S, Holzer H, Tiesenhausen K. [Dialock® – an alternative to Permcath trade mark and Access Graft] [Article in German]. Zentralbl Chir 2003; 128 (9): 753–756Metry G, Uhlin F, Almroth G. Swedish experience of the Dialock. Scand J Urol Nephrol 2007; 41 (3): 249–253Metry G, Uhlin F, Almroth G. Swedish experience of the Dialock. Scand J Urol Nephrol 2007; 41 (3): 249–253Moran JE, Prosl F. Totally implantable subcutaneous devices for hemodialysis access. Contrib Nephrol 2004; 142: 178–192Moran JE, Prosl F. Totally implantable subcutaneous devices for hemodialysis access. Contrib Nephrol 2004; 142: 178–192Rayan SS, Terramani TT, Weiss VJ, Chaikof EL. The LifeSite Hemodialysis Access System in patients with limited access. J Vasc Surg 2003; 38 (4): 714–718Rayan SS, Terramani TT, Weiss VJ, Chaikof EL. The LifeSite Hemodialysis Access System in patients with limited access. J Vasc Surg 2003; 38 (4): 714–718Ross JR. Successful treatment of a LifeSite Hemodialysis Access System pocket infection with large-volume kanamycin solution irrigation. Adv Ren Replace Ther 2003; 10 (3): 248–253Ross JR. Successful treatment of a LifeSite Hemodialysis Access System pocket infection with large-volume kanamycin solution irrigation. Adv Ren Replace Ther 2003; 10 (3): 248–253Szczepanska M, Szprynger K, Stoksik P et al. [Port device central venous access in children with chronic renal disease – personal experience][Article in Polish]. Wiad Lek 2006; 59 (11–12): 814–818Szczepanska M, Szprynger K, Stoksik P et al. [Port device central venous access in children with chronic renal disease – personal experience][Article in Polish]. Wiad Lek 2006; 59 (11–12): 814–818Richard T. Hemodialysis access without a shunt or catheter: the circulating port. J Vasc Access 2007; 8 (2): 86–90Richard T. Hemodialysis access without a shunt or catheter: the circulating port. J Vasc Access 2007; 8 (2): 86–90McAllister TN, Maruszewski M, Garrido SA et al. Effectiveness of haemodialysis access with an autologous tissueengineered vascular graft: a multicentre cohort study. Lancet 2009; 373:1440-1446McAllister TN, Maruszewski M, Garrido SA et al. Effectiveness of haemodialysis access with an autologous tissueengineered vascular graft: a multicentre cohort study. Lancet 2009; 373:1440-1446Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008; 299(18):2164-2171Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008; 299(18):2164-2171Kaufman JL, Garb JL, Berman JA et al. A prospective comparison of two expanded polytetrafluoroethylene grafts for linear forearm hemodialysis access: does the manufacturer matter? J Am Coll Surg 1997; 185(1):74-79Kaufman JL, Garb JL, Berman JA et al. A prospective comparison of two expanded polytetrafluoroethylene grafts for linear forearm hemodialysis access: does the manufacturer matter? J Am Coll Surg 1997; 185(1):74-79Polo JR, Tejedor A, Polo J et al. Long-term follow-up of 6-8 mm brachioaxillary polytetrafluorethylene grafts for hemodialysis. Artif Organs 1995; 19(11):1181-1184Polo JR, Tejedor A, Polo J et al. Long-term follow-up of 6-8 mm brachioaxillary polytetrafluorethylene grafts for hemodialysis. Artif Organs 1995; 19(11):1181-1184Sands J, Miranda CL. Increasing numbers of AV fistulas for hemodialysis access. Clin Nephrol 1997; 48(2):114-117Sands J, Miranda CL. Increasing numbers of AV fistulas for hemodialysis access. Clin Nephrol 1997; 48(2):114-117Miller PE, Tolwani A, Luscy CP et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 1999; 56(1):275-280Miller PE, Tolwani A, Luscy CP et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 1999; 56(1):275-280Lockhart ME, Robbin ML, McNamara MM, Allon M. Association of pelvic arterial calcification with arteriovenous thigh graft failure in haemodialysis patients. Nephrol Dial Transplant 2004; 19(10):2564-2569Lockhart ME, Robbin ML, McNamara MM, Allon M. Association of pelvic arterial calcification with arteriovenous thigh graft failure in haemodialysis patients. Nephrol Dial Transplant 2004; 19(10):2564-2569Lok CE, Allon M, Moist L et al. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006; 17(11):3204-3212Lok CE, Allon M, Moist L et al. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006; 17(11):3204-3212Huijbregts HJ, Bots ML, Wittens CH et al. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 2008; 3:714-719Huijbregts HJ, Bots ML, Wittens CH et al. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 2008; 3:714-719Silva MB Jr, Hobson RW 2nd, Pappas PJ et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27(2):302-307Silva MB Jr, Hobson RW 2nd, Pappas PJ et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27(2):302-307Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 2003; 63:346-352Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 2003; 63:346-352Obialo CI, Tagoe AT, Martin PC, Asche-Crowe PE. Adequacy and survival of autogenous arteriovenous fistula in African American hemodialysis patients. ASAIO J 2003; 49:435-439Obialo CI, Tagoe AT, Martin PC, Asche-Crowe PE. Adequacy and survival of autogenous arteriovenous fistula in African American hemodialysis patients. ASAIO J 2003; 49:435-439Segal JH, Kayler LK, Henke P et al. Vascular access outcomes using the transposed basilic vein arteriovenous fistula. Am J Kidney Dis 2003; 42(1):151-157Segal JH, Kayler LK, Henke P et al. Vascular access outcomes using the transposed basilic vein arteriovenous fistula. Am J Kidney Dis 2003; 42(1):151-157Ravani P, Brunori G, Mandolfo S et al. Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: a prospective multicenter study. J Am Soc Nephrol 2004; 15(1):204-209Ravani P, Brunori G, Mandolfo S et al. Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: a prospective multicenter study. J Am Soc Nephrol 2004; 15(1):204-209van der Linden J, Lameris TW, van den Meiracker AH et al. Forearm venous distensibility predicts successful arteriovenous fistula. Am J Kidney Dis 2006; 47(6):1013-1019van der Linden J, Lameris TW, van den Meiracker AH et al. Forearm venous distensibility predicts successful arteriovenous fistula. Am J Kidney Dis 2006; 47(6):1013-1019Lee T, Barker J, Allon M. Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula. J Am Soc Nephrol 2007; 18(6):1936-1941Lee T, Barker J, Allon M. Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula. J Am Soc Nephrol 2007; 18(6):1936-1941Beathard GA, Settle SM, Shields MW. Salvage of the nonfunctioning arteriovenous fistula. Am J Kidney Dis 1999; 33(5):910-916Beathard GA, Settle SM, Shields MW. Salvage of the nonfunctioning arteriovenous fistula. Am J Kidney Dis 1999; 33(5):910-916Konner K, Hulbert-Shearon TE, Roys EC, Port FK. Tailoring the initial vascular access for dialysis patients. Kidney Int 2002; 62(1):329-338Konner K, Hulbert-Shearon TE, Roys EC, Port FK. Tailoring the initial vascular access for dialysis patients. Kidney Int 2002; 62(1):329-338Faiyaz R, Abreo K, Zaman F et al. Salvage of poorly developed arteriovenous fistulae with percutaneous ligation of accessory veins. Am J Kidney Dis 2002; 39:824-827Faiyaz R, Abreo K, Zaman F et al. Salvage of poorly developed arteriovenous fistulae with percutaneous ligation of accessory veins. Am J Kidney Dis 2002; 39:824-827Falk A, Teodorescu V, Lou WY et al. Treatment of “swing point stenoses” in hemodialysis arteriovenous fistulae. Clin Nephrol 2003; 60(1):35-41Falk A, Teodorescu V, Lou WY et al. Treatment of “swing point stenoses” in hemodialysis arteriovenous fistulae. Clin Nephrol 2003; 60(1):35-41Beathard GA, Arnold P, Jackson J et al. Aggressive treatment of early fistula failure. Kidney Int 2003; 64(4):1487-1494Beathard GA, Arnold P, Jackson J et al. Aggressive treatment of early fistula failure. Kidney Int 2003; 64(4):1487-1494Nassar GM, Nguyen B, Rhee E, Achkar K. Endovascular treatment of the “failing to mature” arteriovenous fistula. Clin J Am Soc Nephrol 2006; 1(2):275-280Nassar GM, Nguyen B, Rhee E, Achkar K. Endovascular treatment of the “failing to mature” arteriovenous fistula. Clin J Am Soc Nephrol 2006; 1(2):275-280Sottiurai VS, Stephens A, Champagne L et al. Comparative results of early and delayed cannulation of arteriovenous graft in haemodialysis. Eur J Vasc Endovasc Surg 1997; 13:139-141Sottiurai VS, Stephens A, Champagne L et al. Comparative results of early and delayed cannulation of arteriovenous graft in haemodialysis. Eur J Vasc Endovasc Surg 1997; 13:139-141Rayner HC, Pisoni RL, Gillespie BWet al. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 63(1):323-330Rayner HC, Pisoni RL, Gillespie BWet al. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 63(1):323-330Brunori G, Ravani P, Mandolfo S et al. Fistula maturation: doesn’t time matter at all? Nephrol Dial Transplant 2005; 20(4):684-687Brunori G, Ravani P, Mandolfo S et al. Fistula maturation: doesn’t time matter at all? Nephrol Dial Transplant 2005; 20(4):684-687Saran R, Dykstra DM, Pisoni RL et al. Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. Nephrol Dial Transplant 2004; 19(9):2334-2340Saran R, Dykstra DM, Pisoni RL et al. Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. Nephrol Dial Transplant 2004; 19(9):2334-2340Saran R, Pisoni RL, Young EW. Timing of first cannulation of arteriovenous fistula: are we waiting too long? Nephrol Dial Transplant 2005; 20(4):688-690Saran R, Pisoni RL, Young EW. Timing of first cannulation of arteriovenous fistula: are we waiting too long? Nephrol Dial Transplant 2005; 20(4):688-690Bonalumi U, Civalleri D, Rovida S et al. Nine years’ experience with end-to-end arteriovenous fistula at the ‘anatomical snuff box’ for maintenance haemodialysis. Br J Surg 1982; 69:486-488Bonalumi U, Civalleri D, Rovida S et al. Nine years’ experience with end-to-end arteriovenous fistula at the ‘anatomical snuff box’ for maintenance haemodialysis. Br J Surg 1982; 69:486-488Munda R, First MR, Alexander JW et al. Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983; 249(2):219-222Munda R, First MR, Alexander JW et al. Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983; 249(2):219-222Young EW, Dykstra DM, Goodkin DA et al. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2002; 61(6):2266-2271Young EW, Dykstra DM, Goodkin DA et al. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2002; 61(6):2266-2271Bender MH, Bruyninckx CM, Gerlag PG. The brachiocephalic elbow fistula: a useful alternative angioaccess for permanent hemodialysis. J Vasc Surg 1994; 20:808-813Bender MH, Bruyninckx CM, Gerlag PG. The brachiocephalic elbow fistula: a useful alternative angioaccess for permanent hemodialysis. J Vasc Surg 1994; 20:808-813Hodges TC, Fillinger MF, Zwolak RM, et al. Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg 1997; 26(6):1009-1019Hodges TC, Fillinger MF, Zwolak RM, et al. Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg 1997; 26(6):1009-1019Coburn MC, Carney WI Jr. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg 1994; 20(6):896-902Coburn MC, Carney WI Jr. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg 1994; 20(6):896-902Iwashima Y, Horio T, Takami Y et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis 2002; 40:974-982Iwashima Y, Horio T, Takami Y et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis 2002; 40:974-982Bay WH, Van Cleef S, Owens M. The hemodialysis access: preferences and concerns of patients, dialysis nurses and technicians, and physicians. Am J Nephrol 1998; 18(5):379-383Bay WH, Van Cleef S, Owens M. The hemodialysis access: preferences and concerns of patients, dialysis nurses and technicians, and physicians. Am J Nephrol 1998; 18(5):379-383III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis 2001; 37:S137-181III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis 2001; 37:S137-181Tesio F, De Baz H, Panarello G et al. Double catheterization of the internal jugular vein for hemodialysis: indications, techniques, and clinical results. Artif Organs 1994; 18(4):301-304Tesio F, De Baz H, Panarello G et al. Double catheterization of the internal jugular vein for hemodialysis: indications, techniques, and clinical results. Artif Organs 1994; 18(4):301-304Saad TF. Bacteriemia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34(6):1114-1124Saad TF. Bacteriemia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34(6):1114-1124Suhocki PV, Conlon PJ Jr, Knelson MH et al. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 1996; 28:379-386Suhocki PV, Conlon PJ Jr, Knelson MH et al. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 1996; 28:379-386Atherikul K, Schwab SJ, Conlon PJ. Adequacy of haemodialysis with cuffed central-vein catheters. Nephrol Dial Transplant 1998; 13:745-749Atherikul K, Schwab SJ, Conlon PJ. Adequacy of haemodialysis with cuffed central-vein catheters. Nephrol Dial Transplant 1998; 13:745-749Dunn J, Nylander W, Richie R. Central venous dialysis access: experience with a dual-lumen, silicone rubber catheter. Surgery 1987; 102(5):784-789Dunn J, Nylander W, Richie R. Central venous dialysis access: experience with a dual-lumen, silicone rubber catheter. Surgery 1987; 102(5):784-789Oliver MJ, Mendelssohn DC, Quinn RR et al. Catheter potency and function after catheter sheath disruption: a pilot study. Clin J Am Soc Nephrol 2007; 2(6):1201-1206Oliver MJ, Mendelssohn DC, Quinn RR et al. Catheter potency and function after catheter sheath disruption: a pilot study. Clin J Am Soc Nephrol 2007; 2(6):1201-1206Oliver MJ, Rothwell DM, Fung K et al. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 2004; 15(7):1936-1942Oliver MJ, Rothwell DM, Fung K et al. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 2004; 15(7):1936-1942Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002; 62(2):620-626Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002; 62(2):620-626Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 2003; 42(5):1013-1019Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 2003; 42(5):1013-1019Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15(2):477-486Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15(2):477-486Thomson PC, Stirling CM, Geddes CC, et al. Vascular access in haemodialysis patients: a modifiable risk factor for bacteremia and death. QJM 2007; 100(7):415-422Thomson PC, Stirling CM, Geddes CC, et al. Vascular access in haemodialysis patients: a modifiable risk factor for bacteremia and death. QJM 2007; 100(7):415-422Pisoni RL, Arrington CJ, Albert JM et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009; 53:475-491Pisoni RL, Arrington CJ, Albert JM et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009; 53:475-491Astor BC, Eustace JA, Powe NR et al. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 2005; 16(5):1449-1455Astor BC, Eustace JA, Powe NR et al. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 2005; 16(5):1449-1455Allon M, Daugirdas J, Depner TA et al. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis 2006; 47(3):469-477Allon M, Daugirdas J, Depner TA et al. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis 2006; 47(3):469-477Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002; 62(4):1109-1124Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002; 62(4):1109-1124Lok CE, Oliver MJ. Overcoming barriers to arteriovenous fistula creation and use. Semin Dial 2003; 16(3):189-196Lok CE, Oliver MJ. Overcoming barriers to arteriovenous fistula creation and use. Semin Dial 2003; 16(3):189-196Yigla M, Nakhoul F, Sabag A et al. Pulmonary hypertension in patients with end-stage renal disease. Chest 2003; 123: 1577-1582Yigla M, Nakhoul F, Sabag A et al. Pulmonary hypertension in patients with end-stage renal disease. Chest 2003; 123: 1577-1582Nakhoul F, Yigla M, Gilman R et al. The pathogenesis of pulmonary hypertension in haemodialysis patients via arteriovenous access. Nephrol Dial Transplant 2005; 20: 1686-1692Nakhoul F, Yigla M, Gilman R et al. The pathogenesis of pulmonary hypertension in haemodialysis patients via arteriovenous access. Nephrol Dial Transplant 2005; 20: 1686-1692

The authors declare that there are no conflicts of interest present.